(Q45273524)

11 December 2017

Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance? (English)

1 reference

11 December 2017

1 reference

Liu Z

1

1 reference

11 December 2017

Luo K

series ordinal

2

1 reference

11 December 2017

He H

series ordinal

3

1 reference

11 December 2017

Hou J

series ordinal

4

1 reference

11 December 2017

1 March 2005

1 reference

Journal of Viral Hepatitis

11 December 2017

1 reference

11 December 2017

12

1 reference

11 December 2017

2

1 reference

11 December 2017

146-153

1 reference

Hepatitis B vaccine -- do we need boosters?

11 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

Regulation of insulin-like growth factor II Gene expression by hepatitis B virus in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00552.X

10.1111/J.1365-2893.2005.00552.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference